BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29324627)

  • 1. Effects of the Humanized Anti-Adrenomedullin Antibody Adrecizumab (HAM8101) on Vascular Barrier Function and Survival in Rodent Models of Systemic Inflammation and Sepsis.
    Geven C; Peters E; Schroedter M; Struck J; Bergmann A; McCook O; Radermacher P; Kox M; Pickkers P
    Shock; 2018 Dec; 50(6):648-654. PubMed ID: 29324627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Effects of Adrenomedullin and the Anti-Adrenomedullin Antibody Adrecizumab in Sepsis.
    Geven C; Bergmann A; Kox M; Pickkers P
    Shock; 2018 Aug; 50(2):132-140. PubMed ID: 29324626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Endothelial Dysfunction in Eight Extreme-Critically Ill Patients with COVID-19 Using the Anti-Adrenomedullin Antibody Adrecizumab (HAM8101).
    Karakas M; Jarczak D; Becker M; Roedl K; Addo MM; Hein F; Bergmann A; Zimmermann J; Simon TP; Marx G; Lütgehetmann M; Nierhaus A; Kluge S
    Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32796765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for Sepsis.
    Geven C; Kox M; Pickkers P
    Front Immunol; 2018; 9():292. PubMed ID: 29520277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects.
    Geven C; van Lier D; Blet A; Peelen R; Ten Elzen B; Mebazaa A; Kox M; Pickkers P
    Br J Clin Pharmacol; 2018 Sep; 84(9):2129-2141. PubMed ID: 29856470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical safety evaluation of the adrenomedullin-binding antibody Adrecizumab in rodents, dogs and non-human primates.
    Geven C; Kox M; Blet A; Mebazaa A; Schroedter M; Struck J; Bergmann A; Pickkers P
    Toxicol Appl Pharmacol; 2019 Apr; 369():1-16. PubMed ID: 30822437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
    Laterre PF; Pickkers P; Marx G; Wittebole X; Meziani F; Dugernier T; Huberlant V; Schuerholz T; François B; Lascarrou JB; Beishuizen A; Oueslati H; Contou D; Hoiting O; Lacherade JC; Chousterman B; Pottecher J; Bauer M; Godet T; Karakas M; Helms J; Bergmann A; Zimmermann J; Richter K; Hartmann O; Pars M; Mebazaa A;
    Intensive Care Med; 2021 Nov; 47(11):1284-1294. PubMed ID: 34605947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrecizumab: an investigational agent for the biomarker-guided treatment of sepsis.
    Deniau B; Takagi K; Asakage A; Mebazaa A
    Expert Opin Investig Drugs; 2021 Feb; 30(2):95-102. PubMed ID: 33256482
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the Non-Neutralizing Humanized Monoclonal Anti-Adrenomedullin Antibody Adrecizumab on Hemodynamic and Renal Injury in a Porcine Two-Hit Model.
    Thiele C; Simon TP; Szymanski J; Daniel C; Golias C; Hartmann O; Struck J; Martin L; Marx G; Schuerholz T
    Shock; 2020 Dec; 54(6):810-818. PubMed ID: 32554994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of the beneficial effects of pentoxifylline during sepsis: maintenance of adrenomedullin responsiveness and downregulation of proinflammatory cytokines.
    Koo DJ; Yoo P; Cioffi WG; Bland KI; Chaudry IH; Wang P
    J Surg Res; 2000 Jun; 91(1):70-6. PubMed ID: 10816353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats.
    Blet A; Deniau B; Geven C; Sadoune M; Caillard A; Kounde PR; Polidano E; Pickkers P; Samuel JL; Mebazaa A
    Intensive Care Med Exp; 2019 May; 7(1):25. PubMed ID: 31093784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrenomedullin in heart failure: pathophysiology and therapeutic application.
    Voors AA; Kremer D; Geven C; Ter Maaten JM; Struck J; Bergmann A; Pickkers P; Metra M; Mebazaa A; Düngen HD; Butler J
    Eur J Heart Fail; 2019 Feb; 21(2):163-171. PubMed ID: 30592365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind, placebo-controlled, randomised, multicentre, proof-of-concept and dose-finding phase II clinical trial to investigate the safety, tolerability and efficacy of adrecizumab in patients with septic shock and elevated adrenomedullin concentration (AdrenOSS-2).
    Geven C; Blet A; Kox M; Hartmann O; Scigalla P; Zimmermann J; Marx G; Laterre PF; Mebazaa A; Pickkers P
    BMJ Open; 2019 Feb; 9(2):e024475. PubMed ID: 30782906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-vascular endothelial growth factor antibody attenuates inflammation and decreases mortality in an experimental model of severe sepsis.
    Jeong SJ; Han SH; Kim CO; Choi JY; Kim JM
    Crit Care; 2013 May; 17(3):R97. PubMed ID: 23710641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin binding improves catecholamine responsiveness and kidney function in resuscitated murine septic shock.
    Wagner K; Wachter U; Vogt JA; Scheuerle A; McCook O; Weber S; Gröger M; Stahl B; Georgieff M; Möller P; Bergmann A; Hein F; Calzia E; Radermacher P; Wagner F
    Intensive Care Med Exp; 2013 Dec; 1(1):21. PubMed ID: 26266790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver X receptor protects against liver injury in sepsis caused by rodent cecal ligation and puncture.
    Wang YY; Ryg U; Dahle MK; Steffensen KR; Thiemermann C; Chaudry IH; Reinholt FP; Collins JL; Nebb HI; Aasen AO; Gustafsson JÅ; Wang JE
    Surg Infect (Larchmt); 2011 Aug; 12(4):283-9. PubMed ID: 21815813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esculentoside A ameliorates cecal ligation and puncture-induced acute kidney injury in rats.
    Sun G; Yang W; Zhang Y; Zhao M
    Exp Anim; 2017 Oct; 66(4):303-312. PubMed ID: 28637971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethyl Fumarate Modulates Oxidative Stress and Inflammation in Organs After Sepsis in Rats.
    Giustina AD; Bonfante S; Zarbato GF; Danielski LG; Mathias K; de Oliveira AN; Garbossa L; Cardoso T; Fileti ME; De Carli RJ; Goldim MP; Barichello T; Petronilho F
    Inflammation; 2018 Feb; 41(1):315-327. PubMed ID: 29124567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperoncotic albumin attenuates lung and intestine injuries caused by peritonitis-induced sepsis in rats.
    Chian CF; Tsao CM; Chen SJ; Chen ZF; Liaw WJ; Ka SM; Huang HC; Wu CC
    J Surg Res; 2013 Jun; 182(1):134-41. PubMed ID: 23088918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fish Oil-Based Fat Emulsion Reduces Acute Kidney Injury and Inflammatory Response in Antibiotic-Treated Polymicrobial Septic Mice.
    Shih JM; Shih YM; Pai MH; Hou YC; Yeh CL; Yeh SL
    Nutrients; 2016 Mar; 8(3):165. PubMed ID: 26999192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.